5-(hydroxymethyl)-2-(trifluoromethyl)-Benzoic acid methyl ester, 95%, 100mg

3-Bromo-7-iodoquinolin-2-amine, 97%, 100mg

4-DODECYL-2,6-DIMETHYLMORPHOLINE, 95.0%, 1g

2,3-Dimethyl-1 H -indole-5-carboxylic acid ethyl ester, 95.0%, 2g

2-(4-Isobutylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

Quinaldine red, 95.0%, 25g

2-Nitro-1-naphthol, 97.0%, 10g

4-(Trifluoromethyl)benzenesulfonamide>98.0%(HPLC)(N)1g

5-Aminobenzo[d]oxazol-2(3H)-one, 95.0%, 25g

4-Fluoro-4-phenylpiperidine hydrochloride, 95+%, 5g

ROTI®Pol ProofRead, 40 µl, 1 x 40 µl

Éther monopropylique de propylèneglycol, min 99%, pour la synthèse, 5 l, emballage plastique.

tert-Butyl ((3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxetan-3-yl)methyl)carbamate, 98%, 250mg